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Next generation sequencing techniques are currently revealing novel insight into the
microbiome of the human gut. This new area of research seems especially relevant
for neonatal diseases, because the development of the intestinal microbiome already
starts in the perinatal period and preterm infants with a still immature gut associated
immune system may be harmed by a dysproportional microbial colonization. For most
gastrointestinal diseases requiring pediatric surgery there is very limited information
about the role of the intestinal microbiome. This review aims to summarize the
current knowledge and outline future perspectives for important pathologies like
necrotizing enterocolitis (NEC) of the newborn, short bowel syndrome (SBS), and
Hirschsprung’s disease associated enterocolitis (HAEC). Only studies applying next
generation sequencing techniques to analyze the diversity of the intestinal microbiome
were included. In NEC patients intestinal dysbiosis could already be detected prior to
any clinical evidence of the disease resulting in a reduction of the bacterial diversity.
In SBS patients the diversity seems to be reduced compared to controls. In children
with Hirschsprung’s disease the intestinal microbiome differs between those with and
without episodes of enterocolitis. One common finding for all three diseases seems
to be an overabundance of Proteobacteria. However, most human studies are based
on fecal samples and experimental data question whether fecal samples actually
represent the microbiome at the site of the diseased bowel and whether the luminal
(transient) microbiome compares to the mucosal (resident) microbiome. In conclusion
current studies already allow a preliminary understanding of the potential role of the
intestinal microbiome in pediatric surgical diseases. Future investigations could clarify
the interface between the intestinal epithelium, its immunological competence and
mucosal microbiome. Advances in this field may have an impact on the understanding
and non-operative treatment of such diseases in infancy.
Keywords: microbiome, necrotizing enterocolitis, short bowel syndrome, Hirschsprung’s disease, pediatric
surgery
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INTRODUCTION
The development of the human microbiome seems to start in the
prenatal period as fetuses may have contact to microorganisms
already in utero (Jimenez et al., 2008; Donnet-Hughes et al.,
2010; Ardissone et al., 2014). However, the major microbial
colonization of the human body starts at birth: During delivery,
by passing the mother’s birth canal, the babies acquire a possibly
optimized set of microorganisms. Mother’s milk, in addition,
provides maternal microbes and prebiotics, which help the gut
microbiome to settle and stabilize (Bode, 2009; Hunt et al.,
2011). Within the ﬁrst years of life, the intestinal microbiome
of infants undergoes abrupt changes until it reaches a similar
status like in adults at approximately three years of age (Palmer
et al., 2007; Yatsunenko et al., 2012). The gut microbiome plays
an important role during the physiological development: It is
extremely important for the diﬀerentiation of gut epithelium,
interacts closely with the gut-associated lymphoid tissue and
inﬂuences activity and morphology of the gastrointestinal tract
(Cebra, 1999; Cho and Blaser, 2012; Guaraldi and Salvatori,
2012; Hooper et al., 2012; Putignani et al., 2014). Thus, the
human development until the age of three is characterized by a
highly sensitive interplay between microorganisms and the body.
Any disturbances like prematurity, formula feeding, treatment
with antibiotics or mode of delivery (Dominguez-Bello et al.,
2011; Cho et al., 2012) may have a direct impact on microbial
abundance and diversity.
The understanding of the microbiome development seems
especially relevant for preterm babies with a gestational age below
the 30th week or a very low birth weight (VLBW, <1500 g)
(Groer et al., 2014). At this age the physiological interaction
between microbes and structural, metabolic, or immunological
functions of the gut remains poorly understood. Moreover, there
is still a very limited knowledge about the inﬂuence of the
microbiome on the development of gastrointestinal diseases in
early infancy (Groer et al., 2014). Thus, the focus of this review
is to provide an in-depth summary of the current knowledge
about the gastrointestinal microbiome in infancy with special
respect to relevant pediatric surgical diseases such as necrotizing
enterocolitis (NEC) of the newborn, short bowel syndrome (SBS),
and Hirschsprung’s disease associated enterocolitis (HAEC).
Necrotizing Enterocolitis
Necrotizing enterocolitis represents a devastating disease
primarily aﬀecting premature infants weighing less than 1,500 g.
It has been shown that 7% of these infants develop NEC,
which carries a mortality rate of up to 30% (Neu and Walker,
2011). Many surviving children subsequently suﬀer from
serious long-term morbidity including intestinal adhesions,
bowel resections and even SBS (Pike et al., 2012) making this
disease highly relevant for the pediatric surgeon. Despite intense
research performed in the ﬁeld, the exact pathogenesis of NEC
has not been revealed yet. Risk factors include gestational age,
birth weight, and formula feeding (Stewart and Cummings,
2015). Since NEC does not occur in germ free mice, bacterial
colonization seems to play a major role in the development
of this disease (Afrazi et al., 2011). In neonates, the intestinal
microbiome plays a pivotal role in the development of the
epithelial barrier function, integrity and the local and system
immune function. Disturbances of the cross-talk between
the intestinal microbial community and the immune system
may initiate an exaggerated inﬂammatory response ultimately
resulting in NEC (Berrington et al., 2013). The association
between bacterial colonization and NEC has been recognized
already some decades ago (Neu, 2013). Since then, numerous
diﬀerent bacteria and also viruses have been related to the
development of NEC. Until recently, examinations of the
intestinal bacterial colonization have been restricted to culture
dependent methodologies.
The advent of culture independent technologies, however,
has driven research and further deepened our understanding
of NEC. There is an increasing number of publications
applying molecular sequencing methods comparing intestinal
microbial proﬁles of infants with and without NEC. Many of
the available reports have demonstrated disturbances of the
intestinal microbiome in infants with NEC. However, the speciﬁc
ﬁndings diﬀer signiﬁcantly among those studies. Mai et al.
(2011) have used high throughput 16S rRNA gene sequencing
of stool samples to compare the diversity of microbiota and the
prevalence of speciﬁc bacterial sequences in nine infants with
NEC and in nine matched controls. Interestingly, microbiota
composition diﬀered in the matched samples collected one
week but not <72 h prior to NEC diagnosis. An increase
of Proteobacteria and a decrease in Firmicutes in NEC cases
collected one week and <72 h prior to NEC diagnosis were
found. Another study with a higher number of patients (11
infants with NEC, 21 matched controls) has demonstrated
a tendency toward a lower alpha-proteobacterial diversity in
infants, who later developed NEC (Morrow et al., 2013).
Furthermore, NEC preceded by Firmicutes dysbiosis occurred
earlier (onset days 7–21) than NEC preceded by Proteobacteria
dysbiosis (onset days 19–39). The lower bacterial diversity of
NEC cases versus controls was conﬁrmed recently (McMurtry
et al., 2015). Microbial diversity and Clostridia abundance
and prevalence even decreased with increasing severity of
NEC. One recently published study has investigated genes
regulating structural proteins such as tight junctions and
cell adhesion in a neonatal rat model of NEC applying a
transcriptomic approach (Hogberg et al., 2013). Several tight
junction genes such as claudins 1, 8, 14, and 15 and gap
junction proteins were found to be involved in the pathogenesis
of NEC.
The disruptions of the intestinal microbial proﬁle prior to the
development of NEC might open the doors for an early detection
and a focused intervention of infants at risk for developing NEC.
However, the currently available results are contradictory and
inconclusive and support the need of future studies.
Moreover, the microbial composition of fecal samples does
not necessarily reﬂect the situation on the mucosa (Haange
et al., 2012). Thus, there is a further need to assess both the
physiological development of the microbiome in the diﬀerent
parts of the intestinal tract and potential disruptions in preterm
infants developing NEC. A slowly growing body of evidence
suggests that in NEC cases there is also a shift of microbes within
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the intestinal mucosa (Carlisle and Morowitz, 2013). However,
no studies have been performed applying deep sequencing
techniques on operative specimen of children suﬀering fromNEC
compared to control groups. Therefore, further research has to
be performed to unravel the inﬂuence of the microbiome on
the distinct pathogenesis of NEC. Another focus would be to
deepen the understanding of microbiome changes prior to NEC
development. Such knowledge could foster potential therapeutic
strategies including treatment with pre- or probiotics and stool
transplantation in order to optimize treatment of infants aﬀected
by this devastating disease.
Short Bowel Syndrome
Short bowel syndrome represents the most common cause for
intestinal failure in children. SBS occurs as a congenital disorder
or results from surgical removal of diseased gut segments aﬀected
by NEC, abdominal wall defects (gastroschisis, omphalocele),
midgut volvulus, intestinal atresia, Hirschsprung’s disease, or
abnormalities of the superior mesenteric artery (Reddy et al.,
2013). The disease-associated loss of absorption capacity of the
intestine leads to an inability to maintain ﬂuid, electrolyte,
nutrients, or micronutrient balances resulting in a frequent
dependency on parenteral nutrition. In a recently published
report from a children’s hospital in Canada the incidence of
SBS was found to be 22 per 1,000 admissions to the neonatal
intensive care unit, which increased further to 43 per 1,000
admissions in premature infants (Wales et al., 2005). The health
burden of SBS is signiﬁcant. A case fatality rate of 27.5–37.5%
has been reported within 1.5–5 year follow-up periods in several
retrospective studies (Reddy et al., 2013). Failure to thrive (body
weight <5th percentile) is seen in more than 70% of patients at
6months and in almost half of the patients at 2.5 years (Sukhotnik
et al., 2002).
The gastrointestinal microbiome of patients suﬀering from
SBS has only been addressed in a very limited number of clinical
studies so far (Table 1). Using stool and colonic biopsy samples
of adult patients with SBS, Joly et al. (2010) have demonstrated
that the microbiome of SBS patients is altered (compared to
controls) with overabundance of Lactobacillus along with a
reduced diversity of Clostridium leptum, Clostridium coccoides,
and Bacteroidetes comparing 11 adult patients with SBS to 8
control patients without intestinal pathologies. However, there
was no statistically signiﬁcant microbiome change comparing
both groups. SBS-associated microbiota with its high prevalence
of Lactobacillus is enriched in facultative anaerobic carbohydrate
fermenting bacteria (Dethlefsen et al., 2006). Since a considerable
amount of fermentable sugars can be consumed by lactobacilli
its high prevalence can be interpreted as an expression of
the adaptive response of the bowel to SBS (Joly et al.,
2009).
Engstrand Lilja et al. (2015) analyzed the microbial proﬁle of
11 children with SBS (5 of them not weaned from parenteral
nutrition) and compared the results to seven healthy siblings.
One of the major ﬁndings was that again diversity (Shannon
index) was signiﬁcantly reduced in children with SBS still on
parenteral nutrition compared to weaned children. Additionally,
there was a signiﬁcant overabundance of Enterobacteriaceae
(belonging to the phylum Proteobacteria) in four out of the
ﬁve children with SBS on parenteral nutrition. The results
demonstrate that intestinal dysbiosis is related to parenteral
nutrition in children suﬀering from SBS. However, it is not clear,
whether the observed changes were a cause or a consequence of
the disease state. Moreover, four out of the ﬁve children with
SBS still on parenteral nutrition were treated with antibiotics
due to suspected episodes of small bowel bacterial overgrowth
(SBBO) at the time of stool sampling. The antibiotic treatment
may be a confounding factor since antibiotics have been shown
to lower the colonization resistance against Enterobacteriaceae
by increasing the inﬂammatory status of the intestinal mucosa
(Spees et al., 2013).
Another study also performed an in-depth analysis of the
intestinal microbiota in children with intestinal failure using
culture-independent phylogenetic microarray analysis (Korpela
et al., 2015). An overabundance of lactobacilli, Proteobacteria,
and Actinobacteria was observed and the overall diversity
and richness were reduced. Proteobacteria, a major phylum
of Gram-negative bacteria, were associated with liver steatosis
and ﬁbrosis, prolonged parenteral nutrition, and liver and
intestinal inﬂammation in SBS. The lipopolysaccharides (LPS)
produced by this Gram-negative strain may explain these results.
An experimental approach using TLR-4 knockout mice (LPS
insensitive) following small bowel resection could represent an
approach to strengthen this assumption.
Further insights into the microbial community changes in
SBS may be generated experimentally. Lapthorne et al. (2013)
have demonstrated in a piglet model of SBS (75% small bowel
resection) a colonic dysbiosis both two and six weeks post-
resection. While the total colonic bacterial number (as assessed
by absolute quantiﬁcation using qPCR) showed no signiﬁcant
diﬀerences either two weeks or six weeks following small
bowel resection, bacterial diversity in the colon was signiﬁcantly
decreased in the resection group at six weeks. Bacteroidetes
were decreased and Fusobacteria increased in the resection
groups compared to their controls. The majority of diﬀerences
were observed at family-level within the Firmicutes phylum and
a general Firmicutes overabundance leading to an increased
Firmicutes/Bacteroidetes ratio at both time points, i.e., 2 and
6 weeks, following small bowel resection. In patients suﬀering
from SBS this ratio and its association with a pro-inﬂammatory
state have not been studied in detail. Moreover little is known
about the characterization of the ‘relative microbiota maturity
index’ and the ‘microbiota-for-age Z-score’, two indices that
have been recently described by Subramanian et al. (2014).
These two metrics are based on the age-discriminatory bacterial
species and a comparison of the observed maturity of a child’s
fecal microbiota to healthy children of his/her chronologic age.
Therefore, these additional parameters facilitate the classiﬁcation
of undernourished states in children and a possible monitoring
tool for applied therapies. The authors have deﬁned a healthy
development of the gut microbiome by applying a machine-
learning-based approach to 16S rRNA datasets generated from
monthly fecal samples. These samples were obtained from a
birth-cohort of children living in an urban slum of Dhaka,
Bangladesh who exhibited consistently healthy growth. These
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TABLE 1 | Number of patients, specimen taken, and main findings of human studies investigating the intestinal microbiome in short bowel syndrome
(SBS).
Patients/diagnosis Specimen Main findings
Joly et al., 2010 n = 11 SBS
n = 8 controls
(adults, monocentric)
Stool samples and
biopsies
• Diversity of microbiota associated with colonic mucosa was
reduced in SBS compared to controls
• Loss of diversity in bacteria from the Clostridium leptum group
and high numbers of Lactobacillus in SBS
• Bacteroidetes tenfold lower in SBS
Engstrand Lilja et al., 2015 n = 11 SBS (n = 5 not weaned
from PN)
n = 7 controls (healthy siblings)
(children, monocentric)
Stool samples • Reduced diversity in SBS children on PN compared to weaned
SBS children
• High relative abundance of Enterobacteriacae in 6 out of 11 SBS
children
Korpela et al., 2015 n = 23 IF (out of these n = 13
SBS)
n = 58 controls
(multicentric)
Stool samples • Reduced diversity and richness in IF
• Overabundance of lactobacilli, Proteobaceria, and Actionbacteria
observed in IF
• Proteobacteria were associated with prolonged PN, liver, and
intestinal inflammation
• Lactobacilli related to advanced liver steatosis mostly after
weaning off PN
• Liver steatosis, bowel length, PN calories, and antibiotic treatment
best explained the microbiota variation of patients with IF
SBS, short bowel syndrome; PN, parenteral nutrition; IF, intestinal failure.
age-discriminatory bacterial species were incorporated into a
model computing the above mentioned indices that compare
postnatal development of a child’s fecal microbiota relative to
healthy children of similar chronologic age. The model was
applied to children with malnutrition of diﬀerent severities. The
obtained results indicated that severe acute malnourishment is
associated with signiﬁcant relative microbiota immaturity that is
only partially ameliorated following two widely used nutritional
interventions (Khichuri-Halwa and a peanut based ready-to-
use therapeutic food). The authors concluded that microbiota
maturity indices provide a microbial measure of human postnatal
development, a way of classifying malnourished states, and a
parameter for judging therapeutic eﬃcacy (Subramanian et al.,
2014). Therefore, assessing these indices would be of interest in
children suﬀering from SBS.
Data conﬂicting the ﬁndings of Lapthorne et al. (2013;
colonic dysbiosis two and six weeks post-resection) were recently
described by Sommovilla et al. (2015) using a murine model.
The authors performed a 50% small bowel resection in C57BL6
mice and collected enteric contents from the small bowel, cecum
and stool at 7 and 90 days postoperatively for subsequent
16S rRNA gene analysis. No signiﬁcant changes in bacterial
diversity scores of stool, cecal, and ileal samples were found
when comparing SBS mice 7 and 90 days following resection
to their corresponding sham group. Additionally, no signiﬁcant
community diﬀerences at the phylum level at any site of the
sampled gastrointestinal tract in the short arm of the study
was found. However, at 90 days following small bowel resection
the ileal contents signiﬁcantly diﬀered driven by a decrease
in Proteobacteria and Actinobacteria when compared to the
respective sham group. Additionally, a comparison of pre-
and postoperative (90 days) stool and ileal samples revealed
increases of Lactobacillus genera. These changes most likely
reﬂect an appropriately adapted community of organisms in
response to bowel resection. The beneﬁcial eﬀects of Lactobacillus
on the gastrointestinal tract include promotion of the innate
immunity and its administration has been demonstrated to
decrease bacterial translocation (Eizaguirre et al., 2011) and to
promote intestinal adaptation (Tolga Muftuoglu et al., 2011).
On the other hand, there are cases of complications associated
with Lactobacillus treatment of children suﬀering from SBS.
Reported complications include bacteremia, sepsis, and D-lactic
acidosis (Kunz et al., 2004; De Groote et al., 2005; Munakata
et al., 2010). Taken together, there is still insuﬃcient evidence
on the eﬀects of probiotics in children with SBS. The safety and
eﬃcacy of probiotic supplementation in this high-risk cohort
needs to be evaluated in larger trials. The authors of the
abovementioned study explained the absence of diﬀerences in
the overall bacterial diversity throughout the gastrointestinal tract
by the fact that unlike other studies perioperative antibiotics
were not used and antibiotics lead to a reduced microbial
diversity (Dethlefsen and Relman, 2011). Additionally, a 50%
small bowel resection might retain suﬃcient intestinal length in
this murine model. In contrast to the ﬁndings of Sommovilla
et al. (2015), a decreased bacterial diversity in the colon in
a murine model of ileocecal resection (removal of 12 cm
ileum, cecum, and proximal right colon) and accompanying
antibiotic treatment has been described recently (Devine et al.,
2013).
In patients suﬀering from SBS, parenteral nutrition, the
frequent use of antibiotics due to recurrent infections and the
accelerated intestinal transit time may all lead to substantial
clinical problems (Kaneko et al., 1997). The altered microbiome-
gut homeostasis in SBS leads to a disrupted gastrointestinal
barrier function and capacity of the microbiota to provide
vitamins and their precursors contributing to the frequent
complications seen in SBS patients such as sepsis, vitamin
deﬁciencies and failure to wean from parenteral nutrition
(Sommovilla et al., 2015). Moreover, SBBO, deﬁned as an increase
of the total number of bacteria per ml content, may develop
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in children with SBS. SBBO is caused by stasis, poor peristalsis,
and intestinal dilatation. Clinically SBBO signiﬁcantly increases
the risk for recurrent blood stream infections and the systemic
proinﬂammatory response decreases with increasing enteral
feeding and weaning parenteral nutrition (Cole et al., 2010).
Taken together, microbiome research of SBS is still in its
infancy. A marked dysbiosis of the gastrointestinal tract seems to
be characteristic for patients suﬀering from SBS. The presently
available data based on next-generation sequencing indicate
that the disruptions of the gastrointestinal microbiome may be
a reason for the pro-inﬂammatory state associated with SBS.
Nevertheless, the precise alterations of the microbiome associated
with SBS, i.e., changes of the transient/resident microbiome
during intestinal adaptation processes, the physiological and
pathophysiological roles of the altered microbes and safe
possibilities of therapeutic manipulations have still to be
unraveled.
Hirschsprung’s Associated Enterocolitis
Hirschsprung’s disease describes a congenital segmental absence
of the enteral nervous system (ENS) in the myenteric and
submucosal plexuses with variable proximal expression due to
a failure of migration of neural crest cells during embryonic
development (Sasselli et al., 2012). The resulting intestinal
obstruction is usually treated by surgical removal of the
aganglionic bowel and a pull-through of unaﬀected ganglionic
bowel.
Despite correct removal of the aganglionic bowel, up to 40%
of the patients continue to suﬀer from Hirschsprung’s associated
enterocolitis (HAEC; Frykman and Short, 2012). HAEC is
deﬁned as a clinical condition with explosive diarrhea, abdominal
distension, fever, and subsequent septic shock (Elhalaby et al.,
1995). Immediate treatment of HAEC patients with bowel
rest, rectal washouts, adequate resuscitation, and antibiotic
treatment has decreased its mortality to about 1%. Even though
a variety of diﬀerent hypotheses have been formulated, the
exact pathophysiology of HAEC is still unclear. Recent studies
have shown that a disruption of the intestinal mucosal barrier,
an abnormal immune response of the intestinal tract and
infection due to speciﬁc pathogens like Clostridium diﬃcile
may play pivotal roles in the development of HAEC (Hong
and Poroyko, 2014). Considering the interrelation between the
epithelium, the immune system and the microbiome of the
intestine, disturbances of the intestinal microbial composition
may predispose a patient to develop HAEC independent of
correct surgical treatment.
Both, experimental and clinical studies recently have given
a ﬁrst insight into an altered intestinal microbiome in
Hirschsprung’s disease and HAEC. Applying 16S rRNA gene
pyrosequencing Ward et al. (2012) assessed the intestinal
microbiome in a murine model of HAEC for the ﬁrst time. The
authors used endothelin receptor B knockout mice (Ednrb –/–)
as an established experimental model of intestinal aganglionosis.
Colonic and fecal samples were analyzed at diﬀerent time
points and compared to wild type mice (WT). WT exhibited
increasing species diversity with age, while mutant mice
possessed an even greater diversity. On the phylum level,
mutant mice contained more Bacteroidetes and less Firmicutes
compared to WT mice. Based on these results the ENS can
be added to the list of regulatory host factors inﬂuencing
microbial composition. These ﬁndings were – at least partially –
conﬁrmed by a study comparing bacterial DNA of cecal contents
between Ednrb knockout and heterozygous mice (Pierre et al.,
2014). The heterozygous mice demonstrated decreased levels
of Bacteroidetes and Proteobacteria with increased Firmicutes
compared to the knockout mice. Additionally, mutant mice
exhibited a reduced ileal expression and activity of secretory
phospholipase A2 (sPLA2), an antimicrobial molecule secreted
by Paneth cells at the base of the intestinal crypts. These
results suggest that Hirschsprung’s disease is not limited to the
absence of ganglia within the gastrointestinal tract, but also aﬀects
the mucosal immune system and subsequently the microbial
composition of the GI tract.
De Filippo et al. (2010) assessed 15 stool samples of a 3-years
old Hirschsprung patient harvested during four HAEC episodes
and remission phases, respectively. The samples were analyzed
using ampliﬁed ribosomal DNA restriction analysis (ARDRA).
This analysis revealed that HAEC episodes clustered together
suggesting a sort of predisposing bacterial community for HAEC
development. The available human studies on HAEC applying
high-throughput sequencing are summarized in Table 2. Yan
et al. (2014) assessed the microbial signature of intestinal contents
taken during surgery from diﬀerent sections along the intestinal
tract in a study population consisting of four patients (two
patients with HEAC and two patients with Hirschsprung’s
disease). Bacteroidetes and Proteobacteria accounted for the
highest proportion among the intestinal ﬂora in Hirschsprung’s
patients. In contrary, Proteobacteria and Firmicutes were the
most common microbes in HAEC patients. At the genus
level, marked diﬀerences comparing HAEC and Hirschsprung’s
patients were observed. The altered Firmicutes/Bacteroidetes
ratio found in this study conﬁrms the above-mentioned changes
described in experimental settings and fuels the speculation that
the increased ratio is associated with a pro-inﬂammatory state
of the intestinal microbiomes. The alterations of the dominating
bacterial phylum reduce the endogenous production of GLP-2,
an intestinal peptide enhancing tight junctions of the cells and
thereby preventing LPS from entering plasma (Cani et al., 2009).
In a larger group of patients suﬀering fromHirschsprung’s disease
consisting of 19 children, 9 with a history of HAEC and 9without,
fecal DNA was isolated and the bacterial and fungal microbiome
was analyzed subsequently (Frykman et al., 2015). Even though
bacterial microbiome analysis revealed some diﬀerences between
the two groups at the phylum level, the changes did not reach
statistical signiﬁcance. In contrast, the fecal fungal composition
(the mycobiome) of the HAEC group showed amarked reduction
in diversity with increased Candida sp. and reduced Malassezia
and Saccharomyces sp. compared with the group of patients
without HAEC. These results therefore identiﬁed Candida sp. as
a potential player in HAEC, either as an expanded commensal
species as a consequence of enterocolitis or its treatment or even
possibly contributing to the pathogenesis of HAEC (Frykman
et al., 2015). Once more it should be emphasized that fecal
samples may not reveal the microbial diversity of the diseased
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TABLE 2 | Number of patients, specimen taken, and main findings of human studies investigating the intestinal microbiome in Hirschsprung’s disease
(HD) and Hirschsprung’s associated enterocolitis.
Patients/diagnosis Specimen Main findings
Yan et al., 2014 n = 2 HAEC
n = 2 HD
(children, monocentric)
Intestinal contents from different
sections along the intestine during
operative procedure
• HAEC patients exhibited greater diversity of bacterial species than HD
patients
• Sharp distinction between microbiota of HAEC and HD
• Phylum level: Proteobacteria (55%) and Firmicutes (18%) in HAEC;
Bacteroidetes (46%) and Proteobacteria (21%) in HD
• Genus level: Enterobacteriaceae (56%) in HAEC; Bacteroides (47%) in HD
Frykman et al., 2015 n = 9 HAEC
n = 2 HD
(children, multicentric)
Stool samples collected after
completed definitive surgery
• HAEC patients exhibited greater diversity of bacterial species than HD
patients
• No significant differences in the proportion of bacterial groups at the
phylum and genus level
• Reduced diversity of fungal species in HAEC compared to HD
• Increased Candida sp. and reduced Malassezia and Saccharomyces sp.
in HAEC
• High burden of C. albicans in some HAEC patients, not found in HD
patients
HAEC, Hirschsprung’s associated enterocolitis; HD, Hirschsprung’s disease.
bowel and even luminal samples may not represent the mucosal
microbiome (Haange et al., 2012). Thus, further research seems
to be mandatory.
Taken together, there is a limited but growing body of
evidence that a shift in the intestinal microbiome with respect to
the colonization with speciﬁc intestinal bacteria may aﬀect the
intestinal immune responses causing a susceptibility to recurrent
life-threatening episodes of HAEC. Additionally, it has already
been shown that an altered transit time due to disruptions of
the intestinal motility is an important factor for shaping the
intestinal microbiome (Gorkiewicz et al., 2013). Nevertheless,
it still seems too early to recommend possibilities to alter the
intestinal microbiome in a therapeutic way. Further studies have
to be performed to reveal the crosstalk between the intestinal
microbiota and the immune system.
DISCUSSION AND FUTURE
PERSPECTIVES
Especially in neonates or preterm babies the immunological,
structural, and metabolic interaction between the microbiome
and the gastrointestinal tract is not completely understood yet.
Latest (and future) 16S rRNA gene-based and metagenomic
analyses may provide novel insights into the development of
the gastrointestinal microbiome in such patients. In addition
to genome-based information, functional data (assessed via
transcriptomics or metabolomics) of the infant microbiome need
to be retrieved allowing the vision of an improved diagnosis and
treatment of infectious diseases in the future.
At present we already have scientiﬁc evidence for diseases like
NEC, SBS, and HAEC that dysbiosis of the microbiome may
inﬂuence the course of the diseases. Further insights into the
molecular interaction between the microbes and the gut, as well
as high-resolution visualization of the interplay seem mandatory
as present data are not conclusive.
One challenge associated with studies of the microbiome in
pediatric surgical diseases like NEC, SBS, and HAEC is the
low incidence of these diseases. The resulting low numbers of
individuals combined with the presence of potential confounding
factors make interpretation of “microbiome data” challenging.
Confounding factors include mode of delivery and feeding
(breast milk vs. formula; enteral vs. parenteral). For instance, in
the case of caesarian delivery a diﬀerent set of environmental
bacteria (similar to the skin communities of the mothers)
form the basis for the infant’s microbiome compared to the
microbiome of infants delivered vaginally (Biasucci et al., 2008;
Dominguez-Bello et al., 2010). Moreover, while the microbiome
of breast-fed infants is dominated by biﬁdobacteria the counts
of Escherichia coli, Clostridium diﬃcile, Bacteroides fragilis, and
lactobacilli are higher in exclusively formula-fed infants (Penders
et al., 2006). In a recently published study it has also been shown
that immaturity and perinatal antibiotics strongly aﬀected the
infant’s microbiome (Arboleya et al., 2015).
Nutrition as well as environmental conditions of the neonatal
intensive care unit can also strongly inﬂuence the microbial
development. For example, it has been shown that human milk
carries pre- and probiotics, which are necessary for an ideal
colonization of the gut and could thus, help pre-term and low-
weight infants to develop optimally (Sela and Mills, 2010).
Moreover, the environment seems to matter. Recent studies
indicate that (neonatal) intensive care units harbor hot spots
of possibly pathogenic microorganisms located on the medical
personnel and equipment (Gastmeier et al., 2007; Oberauner
et al., 2013). Due to the frequent and harsh cleaning processes
in such areas, the natural microbial community is strongly
inﬂuenced and shifted toward a potentially more resistant
microbiome, as it has also been observed for highly cleaned
and monitored clean rooms (Moissl-Eichinger et al., 2013). An
overview summary of neonatal intensive care unit outbreaks has
identiﬁed Klebsiella sp. to be responsible for most outbreaks.
This bacterium, which is widely distributed in various habitats
including the sinks of patient rooms (Leitner et al., 2015),
possesses a polysaccharide capsule, which makes this microbe
more robust against desiccation – a critical feature to survive on
surfaces or on skin.
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Finally the babies age matters. Brooks et al. (2014) have shown
that VLBW infants adopt microorganisms from their hospital
environment. Microbial reservoirs in the rooms inoculate the
infant’s intestinal tract and thus impact the development of the
microbiome. From there, the microorganisms are distributed
again into the environment, creating a cycle of inoculation. In this
study, the most probable reservoirs for diﬀerent microorganisms
were found to be tubings and surfaces, whereas hands or skin
contributed to a lesser extent.
CONCLUSION
The interplay of the microorganisms with VLBW infants
is extremely complex, and understanding the processes and
ﬁnding possibilities to control this sensitive interaction requires
are large (international) collaboration. With the joint goal to
understand the impact of the microbiome on infant development
also geographical diﬀerences between regions for the same
disease can be studied, with the chance to improve health
and development for generations of VLBW- and hospitalized
newborns. However, collecting fecal samples may not be
suﬃcient to deﬁne the microbiome of the diseased bowel,
because Haange et al. (2012) have shown in an experimental
setting that the microbial diversity diﬀered considerably along
the intestinal tract and even the luminal (transient) microbiome
displayed a diﬀerent diversity compared to the mucosal
(resident) microbiome at the same portion of the gut. Finally,
epidemiological studies beyond infancy seem promising to
observe the “normal development” of the microbial diversity
(e.g., in the appendix) and ensure a protective and beneﬁcial
symbiosis.
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